Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arcuate Therapeutics
AddedMar 20, 2024
UpdatedJun 18, 2026
Arcuate Therapeutics

Arcuate Therapeutics

Series A

Boston-based pharmaceutical innovator, Arcuate Therapeutics, offers stealth healthcare solutions.

HQ
Boston, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Arcuate Therapeutics is a provider

of stealth healthcare service.

Arcuate Therapeutics - Similar Companies

Arc Bio logo

Arc Bio

cantatabio.com

Athenen Therapeutics logo

Athenen Therapeutics

Santi Therapeutics logo

Santi Therapeutics

Arete Therapeutics logo

Arete Therapeutics

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

arcutis.com

Manistee Therapeutics logo

Manistee Therapeutics

Chase Therapeutics logo

Chase Therapeutics

Stargazer Pharmaceuticals logo

Stargazer Pharmaceuticals

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Thunder Road Surgical logo

Thunder Road Surgical

Santiste Medical logo

Santiste Medical

Arcus Biosciences logo

Arcus Biosciences

arcusbio.com

Performance Health Sciences logo

Performance Health Sciences

Courage Therapeutics logo

Courage Therapeutics

Resq Pharmaceutical logo

Resq Pharmaceutical

resqpharm.com

Arcuate Therapeutics - Quick Facts

Who are Arcuate Therapeutics' competitors?

Companies similar to Arcuate Therapeutics include Arc Bio, Athenen Therapeutics, Santi Therapeutics and Arete Therapeutics.

When was Arcuate Therapeutics founded?

Arcuate Therapeutics was founded in 2019.

Where is Arcuate Therapeutics' headquarters located?

Arcuate Therapeutics' headquarters is located in Boston, MA, US.

When was Arcuate Therapeutics' last funding round?

Arcuate Therapeutics' most recent funding round was for $5M (USD) in October 2019.

How much has Arcuate Therapeutics raised to-date?

As of Oct 9, 2019, Arcuate Therapeutics has raised a total of $5M (USD).

How many employees does Arcuate Therapeutics have?

Arcuate Therapeutics has 5 employees as of Feb 5, 2024.

Arcuate Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified